Business Context and Reporting Period
Company: MEDIFAST, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: July 17, 2026
Event: Regulation FD Disclosure regarding the rebranding of the company's lifestyle brand and wholly-owned subsidiary, OPTAVIA, to Trilivy, described as a comprehensive metabolic health system.
Key Financial Metrics
This filing is a current report regarding a corporate branding event and does not contain financial statements. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Brand Rebranding: The OPTAVIA brand has been rebranded to Trilivy.
- Strategic Positioning: The new brand is positioned as a "science-backed metabolic health system."
Guidance, Outlook, and Management Commentary
Management announced the rebranding via a press release (Exhibit 99.1) titled "Medifast Enters a New Era: Introducing Trilivy." The filing does not provide specific financial guidance, risk factors, or contingencies related to this event beyond the strategic shift in branding.
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) for details on the transition timeline and marketing strategy for Trilivy.
- Verify the impact of the rebranding on existing customer contracts and distributor agreements in subsequent quarterly reports (10-Q).
- Monitor future filings for any changes in the company's competitive landscape or product mix resulting from the shift to a "metabolic health system" focus.